Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2005
12/01/2005US20050267036 Peptide sequence derived from the C-terminus of CaV2.2. and inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents
12/01/2005US20050267030 Use of deltaPKC peptides for modulation of reactive oxygen species
12/01/2005US20050267019 Echinocandin derivatives, their method of preparation and their application as anti-fungal agents
12/01/2005US20050267016 Therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
12/01/2005US20050266002 Methods for the treatment of cancer using anti-CD40 antibodies
12/01/2005US20050265965 Modified cytokines for use in cancer therapy
12/01/2005CA2571828A1 Bacterial efflux pump inhibitors and methods of treating bacterial infections
12/01/2005CA2566610A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
11/2005
11/30/2005EP1600504A1 Control of transglutaminase catalyzed protein modification by selective irreversible transglutaminase inhibitors
11/30/2005EP1600457A1 Peptide derivatives having beta-secretase inhibitory activity
11/30/2005EP1599496A2 Hepatitis c inhibitor peptide analogs
11/30/2005EP1599216A2 Methods for preventing mitochondrial permeability transition
11/30/2005EP1252179B1 High purity lipopeptides, lipopeptide micelles, processes for preparing same and pharmaceutical compositions containing them
11/30/2005EP0960121B1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
11/30/2005EP0951470B1 Method and pharmaceutical composition for iron delivery in hemodialysis and peritoneal dialysis patients
11/30/2005EP0891377B1 Inhibitor and stimulator of haematopoietic stem cell proliferation and uses thereof
11/30/2005CN1703622A Method of screening groups of radioactive molecules and applications thereof
11/24/2005WO2005111008A2 Compounds for enzyme inhibition
11/24/2005WO2005110456A2 T-cell death-inducing epitopes
11/24/2005WO2005051978A3 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof
11/24/2005US20050261495 Lactam Compound
11/24/2005US20050261473 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides
11/24/2005US20050261472 Binding moieties for fibrin
11/24/2005US20050261203 Azabicyclo-octane inhibitors of IAP
11/24/2005US20050261201 Method of reducing C-reactive protein using growth hormone secretagogues
11/24/2005US20050261200 Inhibiting the replication of hepatitis C virus, therapy, infection
11/24/2005US20050261199 Amidated D-Proline, D-Tyrosine, D-Valine, and D-Leucine, D-Threonine, D-Valline; lowering serum triglyceride levels
11/24/2005US20050261174 Insecticidal activity of a cyclic peptide
11/24/2005US20050261172 Peptide for increasing bone density; peptide is glycosylated, is 4 amino acids in length; the amino acid sequence consists of a sequence identical to the first 4 consecutive amino acids
11/24/2005CA2565872A1 T-cell death-inducing epitopes
11/24/2005CA2565407A1 Compounds for enzyme inhibition
11/23/2005EP1597270A2 Peptidomimetic inhibitors of stat3 activity and their medical uses
11/23/2005EP1390055B1 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/23/2005EP1280777B1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/23/2005EP0929311B1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS
11/22/2005US6967237 For use in stimulating growth hormone secretion
11/17/2005WO2005108594A1 Enzymatic ammonolysis process for the preparation of intermediates for dpp iv inhibitors
11/17/2005WO2005108417A1 Polymeric primer for sugar peptide synthesis
11/17/2005WO2005108365A1 Processes for the preparation of alpha polymorph of perindopril erbumine
11/17/2005WO2005108354A1 Use of biphenyl-derived thiamides as calpain inhibitors
11/17/2005WO2005107789A1 Use of delta pkc peptides for modulation of reactive oxigen species
11/17/2005WO2005107745A1 An inhibitor of hepatitis c
11/17/2005WO2005021577A3 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
11/17/2005US20050257284 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256058 Propenoyl hydrazides
11/17/2005US20050256057 Proline-specific endoprotease and tripeptidase digested polypeptide mixture comprising tripeptides for use in pharmaceuticals and nutraceuticals
11/17/2005US20050256053 Combined use of a GLP-1 compound and another drug for treating dyslipidemia
11/17/2005US20050256049 Chimeric toxins for targeted therapy
11/17/2005US20050256046 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight
11/17/2005US20050256037 Antibacterial amide macrocyles
11/17/2005US20050256034 Dioxolane analogs for improved inter-cellular delivery
11/17/2005US20050256019 contacting 2S)-2-aminocarbonyl-2,3-dihydro-1H-pyrrole-1-carboxylic acid, 1-(1,1-dimethylethyl) ester with an enzyme which is a fraction of B lipase from yeast candida antarctica, to catalyze the ammonolysis of above compound in presence of ammonium carbamate and/or ammonia
11/17/2005US20050255138 Active agent transport systems
11/16/2005EP1595890A2 Synthetic peptide inhibitors of HIV transmission
11/16/2005EP1595547A2 Use of the growth factor AMP for the treatment of gastrointestinal injuries and acute renal failure
11/16/2005EP1594969A2 Active immunization to generate antibodies to soluble a-beta
11/16/2005EP1594442A2 Knockout identification of target-specific sites in peptides
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1324975B1 Dynamic resolution of isomers and resolved isomers
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005CN1696151A Method for synthesizing bursa of Fabricius bursin
11/16/2005CN1227261C Monocyclic compounds with four bifunctional residues having NK-2 antagonist action, its preparation, medicine compositions and uses
11/16/2005CN1227259C Propanolamine derivs. linked with bile acid used for treating disorders of lipid metabolism
11/15/2005US6965055 Process for producing cinnamaldehyde derivatives, use thereof and the like
11/15/2005US6965049 Zwitterionic lipid compound and uses thereof
11/10/2005WO2005105843A2 Hiv protease inhibitors
11/10/2005WO2005105832A2 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005WO2005105828A1 Pseudopeptides growth hormone secretagogues
11/10/2005WO2005105827A2 Compounds for proteasome enzyme inhibition
11/10/2005WO2005105826A1 Tyropeptin a analogue
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2005037860A3 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
11/10/2005US20050250857 Gelling agents
11/10/2005US20050250819 Inhibitors of bacterial type III protein secretion systems
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250706 Processes for the preparation of alpha polymorph of perindopril erbumine
11/10/2005US20050250680 Treating leukemia by administering a cross-linked polypeptide antiapoptosis agent having at least two modified amino acids ("hydrocarbon stapling"); crosslinking increases cell permeability
11/10/2005US20050249740 with cyclodextrins, polyoxyethylene glycol; anticancer agents
11/10/2005US20050249702 (1R,2S,5S)-N-[(1S)-3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide as inhibitor of hepatitis C virus NS3/NS4a serine protease
11/10/2005CA2564613A1 Pseudopeptides growth hormone secretagogues
11/10/2005CA2564179A1 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005CA2562411A1 Compounds for enzyme inhibition
11/09/2005EP1593685A1 Peptide antioxidants from soy protein
11/09/2005EP1549334A4 A pharmaceutical composition comprising a retro-iverso isomer pettide
11/09/2005EP1349829A4 Catalyst modification to enhance neotame production
11/09/2005EP0975353B1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
11/09/2005CN1694719A Casein derived peptides and uses thereof in therapy
11/08/2005US6962942 Azacycloalkanone serine protease inhibitors
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/08/2005US6962904 Elastin peptide analogs and uses thereof
11/08/2005US6962702 Diagnosis of tissue damage, cancer
11/03/2005WO2005103260A1 Process for producing dipeptide
11/03/2005WO2004108070A3 Releasable polymeric conjugates based on aliphatic biodegradable linkers
11/03/2005WO2004072243A3 Macrocyclic hepatitis c serine protease inhibitors
11/03/2005WO2003068168A3 Helical peptidomimetics and use b-amyloid-associated diseases
11/03/2005US20050245759 N-[N-[3-(3-hydroxy-4-methoxyphenyl)propyl]-L-aspartyl]-L-phenylalanine 1-methyl ester; alkylation of a benzaldehyde derivative with acetaldehyde to produce a cinnamaldehyde derivative, catalytic reducion with hydrogen; reductive alkylation with an aspartame; a sweetener in foods, medicines
11/03/2005US20050245565 Diamine derivatives
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245458 Novel compounds as inhibitors of hepatitis C virus NS3 serine protease
1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 307